Article content

Aurora Cannabis Inc. saw revenues jump more than 200 per cent year-over-year in the second quarter, buoyed by strong patient growth and increased sales into Germany.



In the three months leading up to Dec. 31, Aurora, the second-largest Canadian cannabis company both by revenue and market cap, sold $9.7 million worth of cannabis and a further $1.9 million in products and services, according to the company’s financial statements, released on Thursday.

We apologize, but this video has failed to load.

tap here to see other videos from our team. Try refreshing your browser, or Aurora sees cannabis revenues soar on German exports Back to video

That compares with only $3.8 million in total revenue in the second quarter of 2017.

As with all cannabis companies, which have seen the value of their shares skyrocket in the past several months, Aurora’s earnings per share, on a net income of $7.2 million, remain minuscule. Likewise, due to accounting inconsistency across the industry, it’s hard to compare Aurora’s reported gross margin, 73.8 per cent, with its competitors.

Nonetheless the company’s strong growth in sales and medical patient numbers shows it solidifying its front-row position in the burgeoning industry.